Dual thrombolytic therapy with mutant pro-urokinase and low dose alteplase for ischemic stroke : Dual thrombolytic therapy with mutant pro-urokinase and low dose alteplase for ischemic stroke

Medienart:

Klinische Studie

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

WHO International Clinical Trials Registry Platform - (2023) vom: 03. Apr. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: Stroke, Ischemic stroke, Thrombolytic therapy, Treatment
Recruitment Status: Recruiting
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2018-11-26, Last updated: 2023-04-06

ICTRP ID:

NTR7634
NL7409
METC Erasmus MC : 2018-00448-42 EudraCT

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO004534913